Audited Results of Cohance Lifesciences Ltd. Company

(Rs in Cr.) Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Operating Income 1,093.51 1,024.99 1,330.08 1,320.22 1,009.72
Manufacturing Expenses 42.19 124.97 168.93 170.74 120.98
Personnel Expenses 198.30 126.88 100.84 100.48 87.29
Selling Expenses 0 0 0 0 0
Administrative Expenses 189.93 58.17 74.87 67.46 57.23
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 730.94 615.09 747 740.23 569.20
Operating Profit 362.57 409.90 583.08 579.99 440.52
Other Recurring Income 53.98 55.09 44.55 187.79 14.24
Adjusted PBDIT 416.55 464.99 627.63 767.78 454.76
Financial Expenses 8 7.43 5.39 6.23 9.14
Depreciation 57.20 48.79 42.84 39.10 31.64
Other Write offs 0 0 0 0 0
Adjusted PBT 351.35 408.77 579.39 722.45 413.98
Tax Charges 79.64 103.96 146.79 164.35 105.33
Adjusted PAT 271.71 304.82 432.60 558.10 308.65
Non Recurring Items 0.57 -0.29 -0.35 -0.76 0
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 271.71 304.82 432.60 558.10 308.65
Equity Dividend 0 0 203.65 101.83 25.46
Preference Dividend 0 0 0 0 0
Retained Earnings 2,039.34 1,794.59 1,504.98 1,291.39 851.71

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+